NeOnc Technologies Holdings Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 5

Employees

  • Stock Symbol
  • NTHI

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.50
  • (As of Thursday Closing)

NeOnc Technologies Holdings General Information

Description

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Contact Information

Website
www.neonc.com
Formerly Known As
Neonc Technologies California, NAS-ONC
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 23975 Park Sorrento
  • Suite 205
  • Calabasas, CA 91302
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Drug Delivery
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 23975 Park Sorrento
  • Suite 205
  • Calabasas, CA 91302
  • United States

NeOnc Technologies Holdings Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeOnc Technologies Holdings Stock Performance

As of 19-Nov-2026, NeOnc Technologies Holdings’s stock price is $3.50. Its current market cap is $100M with 28.9M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.50 $4.14 $2.50 - $11.38 $100M 28.9M 186K -$1.95

NeOnc Technologies Holdings Financials Summary

As of 30-Sep-2026, NeOnc Technologies Holdings has a trailing 12-month revenue of $40K.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 96,437 201,805
Revenue 40 40 83 70
EBITDA (40,371) (59,933) (9,112) (12,198)
Net Income (43,024) (62,146) (11,898) (14,921)
Total Assets 9,304 2,824 3,417 1,265
Total Debt 310 6,314 25 6,605
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NeOnc Technologies Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeOnc Technologies Holdings‘s full profile, request access.

Request a free trial

NeOnc Technologies Holdings Patents

NeOnc Technologies Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240216293-A1 Use of perillyl alcohol to enhance levo-dopa delivery Pending 28-Apr-2021
WO-2022232347-A1 Use of perillyl alcohol to enhance levo-dopa delivery Inactive 28-Apr-2021
WO-2022221759-A1 Pharmaceutical compositions comprising poh derivatives Inactive 16-Apr-2021
EP-4243794-A1 Treatment of recurrent gioblastoma with perillyl alcohol Pending 12-Nov-2020
EP-4243794-A4 Treatment of recurrent gioblastoma with perillyl alcohol Pending 12-Nov-2020 A61K47/10
To view NeOnc Technologies Holdings’s complete patent history, request access »

NeOnc Technologies Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeOnc Technologies Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NeOnc Technologies Holdings‘s full profile, request access.

Request a free trial

NeOnc Technologies Holdings Investments & Acquisitions (2)

NeOnc Technologies Holdings’s most recent deal was a Corporate Asset Purchase with NeOnc Technologies (Portfolio of Advanced AI, 3D Bioprinting, and Quantum Modeling Technologies) for . The deal was made on 25-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
NeOnc Technologies (Portfolio of Advanced AI, 3D Bioprinting, and Quantum Modeling Technologies) 25-Aug-2025 Corporate Asset Purchase Buildings and Property
JandB Holdings 18-Aug-2025 Merger/Acquisition Other Commercial Products
To view NeOnc Technologies Holdings’s complete investments and acquisitions history, request access »

NeOnc Technologies Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view NeOnc Technologies Holdings’s complete esg history, request access »

NeOnc Technologies Holdings FAQs

  • When was NeOnc Technologies Holdings founded?

    NeOnc Technologies Holdings was founded in 2008.

  • Where is NeOnc Technologies Holdings headquartered?

    NeOnc Technologies Holdings is headquartered in Calabasas, CA.

  • What is the size of NeOnc Technologies Holdings?

    NeOnc Technologies Holdings has 5 total employees.

  • What industry is NeOnc Technologies Holdings in?

    NeOnc Technologies Holdings’s primary industry is Drug Discovery.

  • Is NeOnc Technologies Holdings a private or public company?

    NeOnc Technologies Holdings is a Public company.

  • What is NeOnc Technologies Holdings’s stock symbol?

    The ticker symbol for NeOnc Technologies Holdings is NTHI.

  • What is the current stock price of NeOnc Technologies Holdings?

    As of 19-Nov-2026 the stock price of NeOnc Technologies Holdings is $3.50.

  • What is the current market cap of NeOnc Technologies Holdings?

    The current market capitalization of NeOnc Technologies Holdings is $100M.

  • What is NeOnc Technologies Holdings’s current revenue?

    The trailing twelve month revenue for NeOnc Technologies Holdings is $40K.

  • What is NeOnc Technologies Holdings’s annual earnings per share (EPS)?

    NeOnc Technologies Holdings’s EPS for 12 months was -$1.95.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process